BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
TONX
TON Strategy Co.
There isn't enough reported data to score TONX yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
TONX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| N/A | |
| N/A |
TONX's revenue is currently healthy, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like TONX.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
TONX PE Valuation
TONX has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
TONX Forward outlook
There aren't enough analyst estimates for TONX to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over TONX on earnings quality, reporting a profit while its opponent remains loss making.
TONX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.91 | +$21.62 |
| Q1 2026 | -$5.01 | +$20.73 |
| Q4 2025 | -$5.96 | +$39.27 |
| Q3 2023 | -$2,144.00 | +$256.00 |
| Q2 2023 | -$2,648.00 | +$232.00 |
| Q1 2023 | -$2,718.00 | +$1,122.00 |
| Q4 2022 | -$3,120.00 | +$1,280.00 |
| Q3 2022 | -$2,400.00 | +$3,760.00 |
TONX lost $1.91 per share over the past year, a smaller loss than the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over TONX on profitability, with a higher operating margin.
TONX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $15M | +607% |
| Q1 2026 | $5.3M | +303% |
| Q4 2025 | $5.7M | +694% |
| Q3 2025 | $3.6M | +2720% |
| Q2 2025 | $2.1M | +5638% |
| Q1 2023 | $2.2M | -18% |
| Q4 2022 | $2.2M | -20% |
| Q3 2022 | $2.2M | -25% |
TONX's revenue has grown year over year for five quarters in a row: $15M last quarter, up 607% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 3.2% | +141 points |
| Q1 2026 | -74% | +130 points |
| Q4 2025 | -159% | +354 points |
| Q3 2025 | -602% | +1205 points |
| Q2 2025 | -138% | +6362 points |
| Q1 2025 | -204% | N/A |
| Q4 2024 | -513% | N/A |
| Q3 2024 | -1806% | N/A |
TONX's operating margin was 3.2% last quarter, up 141 points from the same quarter a year ago, near the top of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over TONX on cash generation, producing positive trailing cash flow while its opponent burns cash.
TONX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.9M | -$3.7M |
| Q1 2026 | -$4.7M | -$3.6M |
| Q4 2025 | -$8M | -$6M |
| Q3 2025 | -$9.4M | -$7.7M |
| Q2 2025 | -$2.3M | +$807K |
| Q1 2025 | -$1.1M | +$1.1M |
| Q4 2024 | -$2M | +$109K |
| Q3 2024 | -$1.8M | +$195K |
TONX's free cash flow was −$28M over the past year, against −$7M the year before. Free cash flow isn't a meaningful measure for financial services companies like TONX.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over TONX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
TONX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +466K shares |
| 1 year | +5654% | +57.7M shares |
| 3 years | +484055% | +58.7M shares |
| 5 years | +2027360% | +58.7M shares |
TONX has 59M diluted shares, up 5654% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $6.3M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
TONX Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
TONX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.1 | Neutral |
| Stochastic | 36.8 | Neutral |
TONX's weekly RSI is 55 (neutral) and its Stochastic is 37 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
TONX PE vs Financial Services Sector
TONX has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
TONX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.18 | 15% above |
| 20 week MA | $3.14 | 16% above |
| 50 week MA | $2.89 | 26% above |
| 100 week MA | $4.98 | 27% below |
| 200 week MA | $121.8 | 97% below |
TONX has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
TONX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10,560.0 | $15,680.0 | +48% |
| 2021 | $15,680.0 | $11,280.0 | -28% |
| 2022 | $11,280.0 | $928.0 | -92% |
| 2023 | $928.0 | $34.4 | -96% |
| 2024 | $34.4 | $6.60 | -81% |
| 2025 | $6.60 | $2.19 | -67% |
| 2026 YTD | $2.19 | $3.65 | +67% |
TONX has the edge over BAC on returns for 2026, with the stronger performance.